{"transactions":[{"id":1269725,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-13T23:03:01.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":181,"price":3.87,"value":700.47,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust"}],"balance_after":268,"source":{"system":"sec-edgar","filing":"0000950170-25-020097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025020097/ownership.xml","form_type":"4"}},{"id":1714419,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-12T21:48:50.000Z","date":"2023-12-08","kind":"sale","planned":false,"acquired":false,"shares":27771,"price":0.5199,"value":14438.1429,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-058296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123058296/doc4.xml","form_type":"4"}},{"id":1758189,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-18T21:15:45.000Z","date":"2023-10-16","kind":"sale","planned":false,"acquired":false,"shares":1845,"price":0.6501,"value":1199.4345,"ownership":{"direct":true},"balance_after":27771,"source":{"system":"sec-edgar","filing":"0001209191-23-053102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123053102/doc4.xml","form_type":"4"}},{"id":1759064,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-17T20:12:08.000Z","date":"2023-10-16","kind":"sale","planned":false,"acquired":false,"shares":10957,"price":0.661,"value":7242.577,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee."}],"balance_after":42096,"source":{"system":"sec-edgar","filing":"0001209191-23-052953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123052953/doc4.xml","form_type":"4"}},{"id":1770552,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-02T20:09:31.000Z","date":"2023-09-28","kind":"sale","planned":false,"acquired":false,"shares":1429,"price":0.69,"value":986.01,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee."}],"balance_after":42096,"source":{"system":"sec-edgar","filing":"0001209191-23-051037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123051037/doc4.xml","form_type":"4"}},{"id":1779000,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T21:18:36.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":0.74,"value":2960.0,"ownership":{"direct":true},"balance_after":39348,"source":{"system":"sec-edgar","filing":"0001209191-23-049786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123049786/doc4.xml","form_type":"4"}},{"id":1778999,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T21:18:36.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":9500,"price":0.73,"value":6935.0,"ownership":{"direct":true},"balance_after":43348,"source":{"system":"sec-edgar","filing":"0001209191-23-049786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123049786/doc4.xml","form_type":"4"}},{"id":1778998,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T21:18:36.000Z","date":"2023-09-14","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":0.75,"value":9000.0,"ownership":{"direct":true},"balance_after":52848,"source":{"system":"sec-edgar","filing":"0001209191-23-049786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123049786/doc4.xml","form_type":"4"}},{"id":1917293,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-19T22:00:11.000Z","date":"2023-04-18","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.16,"value":29000.0,"ownership":{"direct":true},"balance_after":64848,"source":{"system":"sec-edgar","filing":"0001209191-23-024898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123024898/doc4.xml","form_type":"4"}},{"id":1917292,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-19T22:00:11.000Z","date":"2023-04-17","kind":"purchase","planned":false,"acquired":true,"shares":26500,"price":1.16,"value":30740.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted-average price at which shares were purchased within a range between $1.14 and $1.17. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":39848,"source":{"system":"sec-edgar","filing":"0001209191-23-024898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123024898/doc4.xml","form_type":"4"}},{"id":1918208,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-18T20:08:29.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":6356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable on the grant date."}],"balance_after":6356,"derivative":{"exercise_price":1.19,"expiration_date":"2033-04-14","underlying":"Common Stock","underlying_shares":6356},"source":{"system":"sec-edgar","filing":"0001209191-23-024646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123024646/doc4.xml","form_type":"4"}},{"id":2369203,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-28T23:29:04.000Z","date":"2022-02-25","kind":"purchase","acquired":true,"shares":20000,"price":1.6,"value":32000.0,"ownership":{"direct":true},"balance_after":467156,"source":{"system":"sec-edgar","filing":"0001209191-22-013741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919122013741/doc4.xml","form_type":"4"}},{"id":2404480,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-10T23:22:45.000Z","date":"2022-02-09","kind":"purchase","acquired":true,"shares":30000,"price":2.5533,"value":76599.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted-average price at which shares were purchased within a range between $2.53 and $2.57. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":447156,"source":{"system":"sec-edgar","filing":"0001209191-22-008580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919122008580/doc4.xml","form_type":"4"}},{"id":2404479,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-10T23:22:45.000Z","date":"2022-02-08","kind":"purchase","acquired":true,"shares":1000,"price":2.54,"value":2540.0,"ownership":{"direct":true},"balance_after":417156,"source":{"system":"sec-edgar","filing":"0001209191-22-008580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919122008580/doc4.xml","form_type":"4"}},{"id":2406540,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-09T21:24:52.000Z","date":"2022-02-04","kind":"purchase","acquired":true,"shares":2000,"price":2.45,"value":4900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The original Form 4, filed on February 8, 2022, is being amended by this Form 4 amendment to include shares purchased directly that were inadvertently omitted in the original filing."}],"balance_after":416156,"source":{"system":"sec-edgar","filing":"0001209191-22-008025","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919122008025/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-08"}},{"id":2406539,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-09T21:24:52.000Z","date":"2022-02-07","kind":"purchase","acquired":true,"shares":42100,"price":2.6076,"value":109779.96,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted-average price at which shares were purchased within a range between $2.50 and $2.6817. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee."}],"balance_after":1523335,"source":{"system":"sec-edgar","filing":"0001209191-22-008025","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919122008025/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-08"}},{"id":2406538,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-09T21:24:52.000Z","date":"2022-02-04","kind":"purchase","acquired":true,"shares":7900,"price":2.3109,"value":18256.11,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee."}],"balance_after":1481235,"source":{"system":"sec-edgar","filing":"0001209191-22-008025","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919122008025/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-08"}},{"id":2408572,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-08T23:52:44.000Z","date":"2022-02-07","kind":"purchase","acquired":true,"shares":42100,"price":2.6076,"value":109779.96,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted-average price at which shares were purchased within a range between $2.50 and $2.6817. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee."}],"balance_after":1523335,"source":{"system":"sec-edgar","filing":"0001209191-22-007837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919122007837/doc4.xml","form_type":"4"}},{"id":2408571,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-08T23:52:44.000Z","date":"2022-02-04","kind":"purchase","acquired":true,"shares":7900,"price":2.3109,"value":18256.11,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee."}],"balance_after":1481235,"source":{"system":"sec-edgar","filing":"0001209191-22-007837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919122007837/doc4.xml","form_type":"4"}},{"id":3407783,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Units","published_at":"2019-09-23T21:03:20.000Z","date":"2019-09-19","kind":"exercise","acquired":false,"shares":75385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The incentive units vested with respect to 25% of the underlying shares on 3/2/2018, with the remaining shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The incentive units do not expire."}],"balance_after":49391,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":75385},"source":{"system":"sec-edgar","filing":"0001209191-19-050515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1287235/000120919119050515/doc4.xml","form_type":"4"}},{"id":3407782,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Units","published_at":"2019-09-23T21:03:20.000Z","date":"2019-09-19","kind":"exercise","acquired":false,"shares":78821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The incentive units vested with respect to 25% of the underlying shares on 12/30/2017, with the remaining shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The incentive units do not expire."}],"balance_after":43225,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":78821},"source":{"system":"sec-edgar","filing":"0001209191-19-050515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1287235/000120919119050515/doc4.xml","form_type":"4"}},{"id":3407781,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-23T21:03:20.000Z","date":"2019-09-19","kind":"exercise","acquired":true,"shares":73960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person received 73,960 shares of common stock on exercise of incentive units, pursuant to the terms of the Odonate Management Holdings, LLC Equity Incentive Plan."}],"balance_after":151291,"source":{"system":"sec-edgar","filing":"0001209191-19-050515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287235/000120919119050515/doc4.xml","form_type":"4"}},{"id":3407780,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-23T21:03:20.000Z","date":"2019-09-19","kind":"exercise","acquired":true,"shares":77331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person received 77,331 shares of common stock on exercise of incentive units, pursuant to the terms of the Odonate Management Holdings, LLC Equity Incentive Plan."}],"balance_after":77331,"source":{"system":"sec-edgar","filing":"0001209191-19-050515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287235/000120919119050515/doc4.xml","form_type":"4"}},{"id":3554462,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T17:04:23.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":2,"derivative":{"exercise_price":7.16,"expiration_date":"2029-04-15","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000920465-19-000062","document":"wf-form4_155553497242392.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000062/wf-form4_155553497242392.xml","form_type":"4"}},{"id":3554461,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-04-17T17:04:23.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":2,"price":6.09,"value":12.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1263895,"source":{"system":"sec-edgar","filing":"0000920465-19-000062","document":"wf-form4_155553497242392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000062/wf-form4_155553497242392.xml","form_type":"4"}},{"id":3570173,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T19:07:14.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":94,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":94,"derivative":{"exercise_price":6.43,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":94},"source":{"system":"sec-edgar","filing":"0000920465-19-000057","document":"wf-form4_155424641950028.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000057/wf-form4_155424641950028.xml","form_type":"4"}},{"id":3570172,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-04-02T19:07:14.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":94,"price":5.47,"value":514.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 03/29/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1263893,"source":{"system":"sec-edgar","filing":"0000920465-19-000057","document":"wf-form4_155424641950028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000057/wf-form4_155424641950028.xml","form_type":"4"}},{"id":3588953,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-19T17:08:23.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":195,"derivative":{"exercise_price":7.64,"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":195},"source":{"system":"sec-edgar","filing":"0000920465-19-000055","document":"wf-form4_155302968832111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000055/wf-form4_155302968832111.xml","form_type":"4"}},{"id":3588952,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-03-19T17:08:23.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":195,"price":6.49,"value":1265.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 3/15/19 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1263799,"source":{"system":"sec-edgar","filing":"0000920465-19-000055","document":"wf-form4_155302968832111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000055/wf-form4_155302968832111.xml","form_type":"4"}},{"id":3620547,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-04T17:33:14.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":261,"derivative":{"exercise_price":5.7,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":261},"source":{"system":"sec-edgar","filing":"0000920465-19-000049","document":"wf-form4_155173878033378.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000049/wf-form4_155173878033378.xml","form_type":"4"}},{"id":3620546,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-03-04T17:33:14.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":261,"price":4.85,"value":1265.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 02/28/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1263604,"source":{"system":"sec-edgar","filing":"0000920465-19-000049","document":"wf-form4_155173878033378.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000049/wf-form4_155173878033378.xml","form_type":"4"}},{"id":3651145,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T18:10:44.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":239,"derivative":{"exercise_price":6.23,"expiration_date":"2029-02-15","underlying":"Common Stock","underlying_shares":239},"source":{"system":"sec-edgar","filing":"0000920465-19-000034","document":"wf-form4_155061783002173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000034/wf-form4_155061783002173.xml","form_type":"4"}},{"id":3651144,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-02-19T18:10:44.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":239,"price":5.3,"value":1266.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 02/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1263343,"source":{"system":"sec-edgar","filing":"0000920465-19-000034","document":"wf-form4_155061783002173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000034/wf-form4_155061783002173.xml","form_type":"4"}},{"id":3661284,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-02-13T18:25:24.000Z","date":"2018-06-08","kind":"gift","acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1263104,"source":{"system":"sec-edgar","filing":"0000920465-19-000032","document":"wf-form5_155010030902407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000032/wf-form5_155010030902407.xml","form_type":"5"}},{"id":3661283,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-02-13T18:25:24.000Z","date":"2018-06-08","kind":"gift","acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1264004,"source":{"system":"sec-edgar","filing":"0000920465-19-000032","document":"wf-form5_155010030902407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000032/wf-form5_155010030902407.xml","form_type":"5"}},{"id":3661282,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-02-13T18:25:24.000Z","date":"2018-06-08","kind":"gift","acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1264904,"source":{"system":"sec-edgar","filing":"0000920465-19-000032","document":"wf-form5_155010030902407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000032/wf-form5_155010030902407.xml","form_type":"5"}},{"id":3661281,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-02-13T18:25:24.000Z","date":"2018-06-08","kind":"gift","acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1265804,"source":{"system":"sec-edgar","filing":"0000920465-19-000032","document":"wf-form5_155010030902407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000032/wf-form5_155010030902407.xml","form_type":"5"}},{"id":3661280,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-02-13T18:25:24.000Z","date":"2018-06-08","kind":"gift","acquired":false,"shares":17742,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1266704,"source":{"system":"sec-edgar","filing":"0000920465-19-000032","document":"wf-form5_155010030902407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000032/wf-form5_155010030902407.xml","form_type":"5"}},{"id":3678285,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T18:13:58.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":246,"derivative":{"exercise_price":6.04,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":246},"source":{"system":"sec-edgar","filing":"0000920465-19-000029","document":"wf-form4_154932202371074.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000029/wf-form4_154932202371074.xml","form_type":"4"}},{"id":3678284,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-02-04T18:13:58.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":246,"price":5.13,"value":1261.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 01/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1284446,"source":{"system":"sec-edgar","filing":"0000920465-19-000029","document":"wf-form4_154932202371074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000029/wf-form4_154932202371074.xml","form_type":"4"}},{"id":3687277,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-25T21:56:46.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":174000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":174000,"derivative":{"exercise_price":5.99,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":174000},"source":{"system":"sec-edgar","filing":"0000920465-19-000018","document":"wf-form4_154847138928307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000018/wf-form4_154847138928307.xml","form_type":"4"}},{"id":3693937,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-17T20:52:25.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":874,"derivative":{"exercise_price":6.75,"expiration_date":"2029-01-15","underlying":"Common Stock","underlying_shares":874},"source":{"system":"sec-edgar","filing":"0000920465-19-000012","document":"wf-form4_154777632884773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000012/wf-form4_154777632884773.xml","form_type":"4"}},{"id":3693936,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-01-17T20:52:25.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":874,"price":5.74,"value":5016.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 01/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1284200,"source":{"system":"sec-edgar","filing":"0000920465-19-000012","document":"wf-form4_154777632884773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000012/wf-form4_154777632884773.xml","form_type":"4"}},{"id":3699393,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-01-09T21:29:45.000Z","date":"2019-01-07","kind":"purchase","acquired":true,"shares":436,"price":5.85,"value":2550.6,"ownership":{"direct":true},"balance_after":1283326,"source":{"system":"sec-edgar","filing":"0000920465-19-000011","document":"wf-form4_154708736639403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000011/wf-form4_154708736639403.xml","form_type":"4"}},{"id":3699392,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-01-09T21:29:45.000Z","date":"2019-01-07","kind":"purchase","acquired":true,"shares":700,"price":5.85,"value":4095.0,"ownership":{"direct":true},"balance_after":1282890,"source":{"system":"sec-edgar","filing":"0000920465-19-000011","document":"wf-form4_154708736639403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000011/wf-form4_154708736639403.xml","form_type":"4"}},{"id":3699391,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-01-09T21:29:45.000Z","date":"2019-01-07","kind":"purchase","acquired":true,"shares":397,"price":5.85,"value":2322.45,"ownership":{"direct":true},"balance_after":1282190,"source":{"system":"sec-edgar","filing":"0000920465-19-000011","document":"wf-form4_154708736639403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000011/wf-form4_154708736639403.xml","form_type":"4"}},{"id":3699390,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-01-09T21:29:45.000Z","date":"2019-01-07","kind":"purchase","acquired":true,"shares":98,"price":5.85,"value":573.3,"ownership":{"direct":true},"balance_after":1281793,"source":{"system":"sec-edgar","filing":"0000920465-19-000011","document":"wf-form4_154708736639403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000011/wf-form4_154708736639403.xml","form_type":"4"}},{"id":3699389,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-01-09T21:29:45.000Z","date":"2019-01-07","kind":"purchase","acquired":true,"shares":287,"price":5.85,"value":1678.95,"ownership":{"direct":true},"balance_after":1281695,"source":{"system":"sec-edgar","filing":"0000920465-19-000011","document":"wf-form4_154708736639403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000011/wf-form4_154708736639403.xml","form_type":"4"}},{"id":3699388,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-01-09T21:29:45.000Z","date":"2019-01-07","kind":"purchase","acquired":true,"shares":82,"price":5.85,"value":479.7,"ownership":{"direct":true},"balance_after":1281408,"source":{"system":"sec-edgar","filing":"0000920465-19-000011","document":"wf-form4_154708736639403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000011/wf-form4_154708736639403.xml","form_type":"4"}},{"id":3708185,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-03T20:04:12.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable on December 31, 2019, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":12500,"derivative":{"exercise_price":14.08,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-001507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287235/000120919119001507/doc4.xml","form_type":"4"}},{"id":3710595,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-03T19:51:48.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":154,"derivative":{"exercise_price":9.43,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":154},"source":{"system":"sec-edgar","filing":"0000920465-19-000002","document":"wf-form4_154656309146409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000002/wf-form4_154656309146409.xml","form_type":"4"}},{"id":3710594,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2019-01-03T19:51:48.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":154,"price":8.0155,"value":1234.387,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 12/31/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1281326,"source":{"system":"sec-edgar","filing":"0000920465-19-000002","document":"wf-form4_154656309146409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000002/wf-form4_154656309146409.xml","form_type":"4"}},{"id":3729841,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-17T20:28:59.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":112,"derivative":{"exercise_price":12.8,"expiration_date":"2028-12-14","underlying":"Common Stock","underlying_shares":112},"source":{"system":"sec-edgar","filing":"0000920465-18-000067","document":"wf-form4_154509652289022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000067/wf-form4_154509652289022.xml","form_type":"4"}},{"id":3729840,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2018-12-17T20:28:59.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":112,"price":10.88,"value":1218.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 12/14/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1281172,"source":{"system":"sec-edgar","filing":"0000920465-18-000067","document":"wf-form4_154509652289022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000067/wf-form4_154509652289022.xml","form_type":"4"}},{"id":3746664,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-03T21:56:30.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":100,"derivative":{"exercise_price":14.47,"expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0000920465-18-000062","document":"wf-form4_154389217444229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000062/wf-form4_154389217444229.xml","form_type":"4"}},{"id":3746663,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2018-12-03T21:56:30.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":100,"price":12.2995,"value":1229.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 11/30/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1281060,"source":{"system":"sec-edgar","filing":"0000920465-18-000062","document":"wf-form4_154389217444229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000062/wf-form4_154389217444229.xml","form_type":"4"}},{"id":3759783,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-19T17:06:38.000Z","date":"2018-11-15","kind":"grant","acquired":true,"shares":97,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":97,"derivative":{"exercise_price":14.9,"expiration_date":"2028-11-15","underlying":"Common Stock","underlying_shares":97},"source":{"system":"sec-edgar","filing":"0000920465-18-000059","document":"wf-form4_154266517918605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000059/wf-form4_154266517918605.xml","form_type":"4"}},{"id":3759782,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2018-11-19T17:06:38.000Z","date":"2018-11-15","kind":"grant","acquired":true,"shares":97,"price":12.665,"value":1228.505,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 11/15/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1280960,"source":{"system":"sec-edgar","filing":"0000920465-18-000059","document":"wf-form4_154266517918605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000059/wf-form4_154266517918605.xml","form_type":"4"}},{"id":3778430,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-01T20:41:26.000Z","date":"2018-10-31","kind":"grant","acquired":true,"shares":89,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":89,"derivative":{"exercise_price":16.3,"expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":89},"source":{"system":"sec-edgar","filing":"0000920465-18-000051","document":"wf-form4_154111927037311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000051/wf-form4_154111927037311.xml","form_type":"4"}},{"id":3778429,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2018-11-01T20:41:26.000Z","date":"2018-10-31","kind":"grant","acquired":true,"shares":89,"price":13.855,"value":1233.095,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 10/31/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1280863,"source":{"system":"sec-edgar","filing":"0000920465-18-000051","document":"wf-form4_154111927037311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000051/wf-form4_154111927037311.xml","form_type":"4"}},{"id":3791393,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-15T20:52:02.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":88,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":88,"derivative":{"exercise_price":16.25,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":88},"source":{"system":"sec-edgar","filing":"0000920465-18-000040","document":"wf-form4_153965110602270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000040/wf-form4_153965110602270.xml","form_type":"4"}},{"id":3791392,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2018-10-15T20:52:02.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":88,"price":13.81,"value":1215.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 10/15/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1280774,"source":{"system":"sec-edgar","filing":"0000920465-18-000040","document":"wf-form4_153965110602270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000040/wf-form4_153965110602270.xml","form_type":"4"}},{"id":4060306,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2018-02-14T21:52:36.000Z","date":"2017-10-05","kind":"gift","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a bona fide gift to a not-for-profit charitable entity"}],"balance_after":1282686,"source":{"system":"sec-edgar","filing":"0000899243-18-004076","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000089924318004076/doc5.xml","form_type":"5"}},{"id":4060305,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2018-02-14T21:52:36.000Z","date":"2017-10-02","kind":"gift","acquired":false,"shares":71400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents bona fide gifts to two not-for-profit charitable entities"}],"balance_after":1282686,"source":{"system":"sec-edgar","filing":"0000899243-18-004076","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000089924318004076/doc5.xml","form_type":"5"}},{"id":4107218,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-04T20:57:06.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,500 shares of the Issuer's Common Stock, which shall be fully vested and exercisable on January 2, 2019."}],"balance_after":12500,"derivative":{"exercise_price":24.73,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-002272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287235/000120919118002272/doc4.xml","form_type":"4"}},{"id":4119334,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-29T17:04:05.000Z","date":"2017-12-27","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":25000,"derivative":{"exercise_price":32.47,"expiration_date":"2027-12-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000920465-17-000089","document":"wf-form4_151458503165979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046517000089/wf-form4_151458503165979.xml","form_type":"4"}},{"id":4133860,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-13T21:05:53.000Z","date":"2017-12-11","kind":"grant","acquired":true,"shares":183000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of the grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":183000,"derivative":{"exercise_price":28.1,"expiration_date":"2027-12-11","underlying":"Common Stock","underlying_shares":183000},"source":{"system":"sec-edgar","filing":"0000920465-17-000078","document":"wf-form4_151321713894213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046517000078/wf-form4_151321713894213.xml","form_type":"4"}},{"id":4401287,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2017-03-06T16:02:20.000Z","date":"2017-03-03","kind":"purchase","acquired":true,"shares":1000,"price":34.15,"value":34150.0,"ownership":{"direct":true},"balance_after":1354086,"source":{"system":"sec-edgar","filing":"0000920465-17-000037","document":"wf-form4_148883412602740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046517000037/wf-form4_148883412602740.xml","form_type":"4"}},{"id":4401286,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2017-03-06T16:02:20.000Z","date":"2017-03-02","kind":"purchase","acquired":true,"shares":2000,"price":34.1773,"value":68354.6,"ownership":{"direct":true},"balance_after":1353086,"source":{"system":"sec-edgar","filing":"0000920465-17-000037","document":"wf-form4_148883412602740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046517000037/wf-form4_148883412602740.xml","form_type":"4"}},{"id":4496932,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-06T18:24:00.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":214700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 214,700 shares of the Issuer's Common Stock one quarter of which shall be fully vested and exercisable on January 4, 2018, with the remaining 161,025 shares vesting monthly thereafter over the next three years."}],"balance_after":214700,"derivative":{"exercise_price":19.19,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":214700},"source":{"system":"sec-edgar","filing":"0000920465-17-000019","document":"wf-form4_148374502762395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046517000019/wf-form4_148374502762395.xml","form_type":"4"}},{"id":4510043,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":83260,"kind":"person","name":"TIDMARSH GEORGE F","position":1,"cik":"0001287235","reported_name":"TIDMARSH GEORGE F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & Secretary"}}],"security":"Common Stock","published_at":"2016-12-30T21:46:34.000Z","date":"2016-12-28","kind":"gift","acquired":false,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents bona fide gifts to two not-for-profit public charitable entities."}],"balance_after":1351086,"source":{"system":"sec-edgar","filing":"0000899243-16-036468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000089924316036468/doc4.xml","form_type":"4"}}]}